PFSC
NVO

Peoples Financial Services Corp’s Novo Nordisk NVO Stock Holding History

Peoples Financial Services Corp’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Sell
4,442
-87
-2% -$3.74K 0.09% 133
2026
Q1 		$166K Sell
4,529
-7
-0.2% -$332 0.08% 142
2025
Q4 		$231K Sell
4,536
-2,155
-32% -$110K 0.11% 130
2025
Q3 		$371K Sell
6,691
-775
-10% -$45.4K 0.17% 105
2025
Q2 		$515K Sell
7,466
-1,010
-12% -$68.7K 0.25% 88
2025
Q1 		$589K Buy
8,476
+27
+0.3% +$2.23K 0.28% 88
2024
Q4 		$727K Buy
8,449
+727
+9% +$78.6K 0.34% 76
2024
Q3 		$919K Buy
7,722
+260
+3% +$34.7K 0.42% 68
2024
Q2 		$1.07M Buy
7,462
+511
+7% +$67.7K 0.48% 58
2024
Q1 		$892K Buy
6,951
+2,913
+72% +$347K 0.39% 74
2023
Q4 		$418K Buy
4,038
+1,726
+75% +$171K 0.18% 107
2023
Q3 		$210K Buy
2,312
+2,112
+1,056% +$186K 0.1% 130
2023
Q2 		$16.2K Hold
200
– – 0.01% 200
2023
Q1 		$15.9K Hold
200
– – 0.01% 202
2022
Q4 		$13.5K Hold
200
– – 0.01% 211
2022
Q3 		$10K Hold
200
– – 0.01% 226
2022
Q2 		$11K Hold
200
– – 0.01% 227
2022
Q1 		$11K Hold
200
– – ﹤0.01% 233
2021
Q4 		$11K Hold
200
– – ﹤0.01% 226
2021
Q3 		$10K Hold
200
– – ﹤0.01% 228
2021
Q2 		$8K Hold
200
– – ﹤0.01% 246
2021
Q1 		$7K Hold
200
– – ﹤0.01% 245
2020
Q4 		$7K Hold
200
– – ﹤0.01% 241
2020
Q3 		$7K Hold
200
– – ﹤0.01% 224
2020
Q2 		$7K Hold
200
– – ﹤0.01% 228
2020
Q1 		$6K Hold
200
– – ﹤0.01% 238
2019
Q4 		$6K Hold
200
– – ﹤0.01% 266
2019
Q3 		$5K Hold
200
– – ﹤0.01% 283
2019
Q2 		$5K Hold
200
– – ﹤0.01% 288
2019
Q1 		$5K Hold
200
– – ﹤0.01% 279
2018
Q4 		$5K Hold
200
– – ﹤0.01% 274
2018
Q3 		$5K Hold
200
– – ﹤0.01% 294
2018
Q2 		$5K Hold
200
– – ﹤0.01% 281
2018
Q1 		$5K Buy
+200
New +$5.25K ﹤0.01% 283

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Peoples Financial Services Corp's NVO Position: Q2 2026 in Review

Peoples Financial Services Corp reduced its Novo Nordisk (NVO) stake by 1.9% in Q2 2026, selling an estimated $3.74K and leaving 4,442 shares worth $213K. The position accounts for 0.09% of the portfolio, ranked #133.

Peoples Financial Services Corp first reported a position in NVO in Q1 2018 and has held it in 34 quarters since. The position peaked at $1.07M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Peoples Financial Services Corp held 4,442 shares of Novo Nordisk worth $213K as of Q2 2026.
  • Peoples Financial Services Corp sold 87 Novo Nordisk shares in Q2 2026, an estimated $3.74K.
  • Novo Nordisk made up 0.09% of Peoples Financial Services Corp's portfolio in Q2 2026, its #133 holding.
  • Peoples Financial Services Corp first reported a position in Novo Nordisk in Q1 2018 and has held it in 34 quarters since.
  • Peoples Financial Services Corp's Novo Nordisk position peaked at $1.07M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Peoples Financial Services Corp's 13F filing for Q2 2026, filed 22 Jul 2026.